Top Markets
Coin of the day
Malin Corporation plc Malin Corporation plc

Malin Corporation plc

MLC
Rang in Aktien #20971
Malin Corporation plc, through its subsidiaries, operates in the life sciences... Malin Corporation plc, through its subsidiaries, operates in the life sciences industry in Ireland and the United States. It offers life-saving cell and gene therapies for patients with high unmet medical need; medicines to address unmet needs in cancer, infection, and autoimmune diseases; and treatment of recurrent vulvovaginal candidiasis, an unmet need in women's health and onychomycosis or fungal nail infection. The company also provides drugs for protein misfolding diseases; and platform to distinguish disease-driving bacteria from the intestinal microbiota, as well as UV-light disinfection technology solutions. In addition, it provides company secretarial services. Malin Corporation plc was incorporated in 2014 and is headquartered in Dublin, Ireland.
Aktienkurs
$9.13
Marktkapitalisierung
$39.27K
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
-11.76%
Land
IE
Handel Malin Corporation plc (MLC)

Kategorie

EPS für Malin Corporation plc (MLC)
EPS zum December 2025 TTM: $-0.80
Laut den aktuellen Finanzberichten und dem Aktienkurs von Malin Corporation plc beträgt das aktuelle EPS des Unternehmens (TTM) $-0.80. Am Ende des Jahres 2023 betrug das EPS 0.00 eine Steigerung gegenüber dem EPS von 2022, das $0.41 betrug.
EPS-Verlauf von Malin Corporation plc von 2015 bis 2026
EPS am Ende jedes Jahres
Jahr EPS ändert
2026 (TTM) $-0.80 0.00%
2024 0.00 0.00%
2023 0.00 -100.00%
2022 $0.41 450.07%
2021 $0.07 -96.81%
2020 $2.33 -1,985.01%
2019 $-0.12 -89.37%
2018 $-1.16 -59.02%
2017 $-2.83 26.95%
2016 $-2.23 26.03%
2015 $-1.77 0.00%
EPS für ähnliche Unternehmen oder Wettbewerber
Unternehmen EPS EPS-Differenz Land
$1.57 -297.07%
FR
$7.03 -980.91%
DE
$0.23 -129.34%
JP
$6.03 -855.83%
US
$0.51 -163.44%
IN